Active	Status	Sponsor type	Region	Phase	Filter
2 Active 4 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
23-valent PPV / Sinovac
NCT05477693: Immunogenicity and Safety of 23-valent Pneumococcal Polysaccharide Vaccine	Completed	4	1800	RoW	Experimental 23-valent PPV, Control 23-valent PPV	Sinovac Biotech Co., Ltd	Pneumococcal Infections	04/23	04/23
NCT05731115: Lot-to-lot Consistency of 23-valent Pneumococcal Polysaccharide Vaccine	Completed	4	1800	RoW	Experimental 23-valent Pneumococcal	Sinovac Biotech Co., Ltd	Pneumococcal Infections	05/23	05/23

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
23-valent PPV / Sinovac
NCT05477693: Immunogenicity and Safety of 23-valent Pneumococcal Polysaccharide Vaccine	Completed	4	1800	RoW	Experimental 23-valent PPV, Control 23-valent PPV	Sinovac Biotech Co., Ltd	Pneumococcal Infections	04/23	04/23
NCT05731115: Lot-to-lot Consistency of 23-valent Pneumococcal Polysaccharide Vaccine	Completed	4	1800	RoW	Experimental 23-valent Pneumococcal	Sinovac Biotech Co., Ltd	Pneumococcal Infections	05/23	05/23